Participants 65 86 3
hemodialysis patients
Participants 265 414 8
80 stable chronic hemodialysis patients selected on the basis of their acceptable control of serum phosphorus (P) levels with aluminum hydroxide (AH)
Participants 416 491 3
All patients were dialyzed against the same calcium dialyzate (1.62 mmol/l)
